Policy Challenges and Opportunities for Digital Therapeutics in the Mental Health and Substance Use Crisis

What role do digital therapeutics have in addressing the mental health and substance use crisis? Join Mental Health America, the American Psychological Association, and the American Psychiatric Association virtually on April 6th at 2pm ET to hear from federal leadership and experts from practice, industry, and academia to learn more about policy challenges and opportunities facing the field. Register for the webinar and learn more at https://www.apa.org/events/2022/digital-therapeutics .

Speakers include:
● Dr. Meena Seshamani, Director of the Center for Medicare at CMS
● Mr. Bakul Patel, Director of the Digital Health Center of Excellence at FDA
● Nathaniel Counts, JD, SVP, Behavioral Health Innovation, Mental Health America
● Dr. John Torous, Director, Digital Psychiatry Division, Department of Psychiatry, Beth Israel Deaconess Medical Center
● Dr. Trina Histon, Kaiser Permanente Senior Principal Consultant, Prevention, Wellness & Digital Health
● Dr. Steve Chan, Chair, Committee on Innovation, APA
● Dr. Juliette McClendon, Big Health, Director of Medical Affairs
● Dr. Vaile Wright, Senior Director, Health Care Innovation, Practice Directorate, American Psychological Association